Oncolytics Biotech (ONCY) Share-based Compensation (IS) (2009 - 2010)
Oncolytics Biotech (ONCY) posted quarterly Share-based Compensation (IS) of $2.9 million for Q4 2010, up 619.73% year-over-year from $396110.0 in Q4 2009, and down 49.03% quarter-over-quarter from $5.6 million in Q3 2010.
Oncolytics Biotech (ONCY) Share-based Compensation (IS) (2009 - 2010) Analysis & Trends
Oncolytics Biotech (ONCY) has reported Share-based Compensation (IS) for 2 consecutive years, with $2.9 million the latest figure, recorded in Q4 2010.
- In Q4 2010, Share-based Compensation (IS) rose 619.73% year-over-year to $2.9 million; the TTM figure through Dec 2010 stood at $13.6 million (up 3115.08% YoY), while the FY2010 annual figure was $8.4 million, up 1890.27% from the prior year.
- Share-based Compensation (IS) declined to $2.9 million in Q4 2010 per ONCY's latest filing, from $5.6 million in the prior quarter.
- Across five years, Share-based Compensation (IS) topped out at $5.6 million in Q3 2010 and bottomed at $1029.0 in Q1 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (IS) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.11 Bn | 59.92 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.73 Bn | 50.59 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.64 Bn | 28.33 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.32 Bn | 26.49 Bn | - | - |
| 10 | Oncolytics Biotech | 98.95 Mn | 98.95 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 2.85 Mn |
| Dec 31, 2010 | 2.85 Mn |
| Sep 30, 2010 | 5.59 Mn |
| Sep 30, 2010 | 5.59 Mn |
| Jun 30, 2010 | 5.20 Mn |
| Jun 30, 2010 | 5.20 Mn |
| Mar 31, 2010 | 1,029.00 |
| Mar 31, 2010 | 1,029.00 |
| Dec 31, 2009 | 396,110.00 |
| Dec 31, 2009 | 396,110.00 |
| Sep 30, 2009 | 7,982.00 |
| Sep 30, 2009 | 7,982.00 |
| Jun 30, 2009 | 8,544.00 |
| Jun 30, 2009 | 8,544.00 |
| Mar 31, 2009 | 11,637.00 |
| Mar 31, 2009 | 11,637.00 |